Institution
Tulane University
Education•New Orleans, Louisiana, United States•
About: Tulane University is a education organization based out in New Orleans, Louisiana, United States. It is known for research contribution in the topics: Population & Blood pressure. The organization has 24478 authors who have published 47205 publications receiving 1944993 citations. The organization is also known as: University of Louisiana.
Topics: Population, Blood pressure, Receptor, Poison control, Medicine
Papers published on a yearly basis
Papers
More filters
••
TL;DR: Work from several laboratories has implicated PTP-1B as a negative regulator of insulin action and as a potentially important mediator in the pathogenesis of insulin-resistance and non-insulin dependent diabetes mellitus (NIDDM).
Abstract: Insulin signaling involves a dynamic cascade of protein tyrosine phosphorylation and dephosphorylation. Most of our understanding of this process comes from studies focusing on tyrosine kinases, which are signal activators. Our knowledge of the role of protein-tyrosine phosphatases (PTPases), signal attenuators, in regulating insulin signal transduction remains rather limited. Protein-tyrosine phosphatase 1B (PTP-1B), the prototypical PTPase, is ubiquitously and abundantly expressed. Work from several laboratories, including our own, has implicated PTP-1B as a negative regulator of insulin action and as a potentially important mediator in the pathogenesis of insulin-resistance and non-insulin dependent diabetes mellitus (NIDDM).
265 citations
••
University of Sydney1, University of Utah2, Vaccine and Infectious Disease Organization3, University of Glasgow4, University of California, Berkeley5, University of California, San Diego6, University of California, Davis7, Imperial College London8, Pennsylvania State University9, University of Melbourne10, Wellcome Trust11, University of Otago12, Xi'an Jiaotong-Liverpool University13, Texas A&M University14, King's College London15, Medical University of Vienna16, University of Pennsylvania17, University of Arizona18, Scripps Research Institute19, Tulane University20, University of Edinburgh21
TL;DR: In this article, a review of the current scientific evidence that may help clarify the origin of SARS-CoV-2 is presented, with a focus on how severe acute respiratory syndrome coronavirus 2 emerged in the human population.
264 citations
••
TL;DR: It is suggested that the induction of miR-155 by EBV contributes to EBV-mediated signaling in part through the modulation of transcriptional regulatory factors.
Abstract: The cellular microRNA miR-155 has been shown to be involved in lymphocyte activation and is expressed in Epstein-Barr virus (EBV)-infected cells displaying type III latency gene expression but not type I latency gene expression. We show here that the elevated levels of miR-155 in type III latency cells is due to EBV gene expression and not epigenetic differences in cell lines tested, and we show that expression in EBV-infected cells requires a conserved AP-1 element in the miR-155 promoter. Gene expression analysis was carried out in a type I latency cell line transduced with an miR-155-expressing retrovirus. This analysis identified both miR-155-suppressed and -induced cellular mRNAs and suggested that in addition to direct targeting of 3′ untranslated regions (UTRs), miR-155 alters gene expression in part through the alteration of signal transduction pathways. 3′ UTR reporter analysis of predicted miR-155 target genes identified the transcriptional regulatory genes encoding BACH1, ZIC3, HIVEP2, CEBPB, ZNF652, ARID2, and SMAD5 as miR-155 targets. Western blot analysis of the most highly suppressed of these, BACH1, showed lower expression in cells transduced with a miR-155 retrovirus. Inspection of the promoters from genes regulated in EBV-infected cells and in cells infected with an miR-155 retrovirus identified potential binding sequences for BACH1 and ZIC3. Together, these experiments suggest that the induction of miR-155 by EBV contributes to EBV-mediated signaling in part through the modulation of transcriptional regulatory factors.
264 citations
••
TL;DR: Higher blood lead levels remain associated with a higher burden of chronic kidney and peripheral arterial diseases among the overall population and with hypertension among non-Hispanic blacks and Mexican Americans.
Abstract: Background Declines in blood lead levels between 1976 and 1991 among US adults have been previously reported. More recent trends in blood lead levels and the association of lower blood lead levels with chronic disease have not been reported. Methods Data from 2 nationally representative cross-sectional surveys, the Third National Health and Nutrition Examination Survey conducted in 1988-1994 (n = 16 609) and the National Health and Nutrition Examination Survey conducted in 1999-2002 (n = 9961) were analyzed. Results The geometric mean blood lead level declined 41% from 2.76 μg/dL (0.13 μmol/L) in 1988-1994 to 1.64 μg/dL (0.08 μmol/L) in 1999-2002. The percentage of adults with blood lead levels of 10 μg/dL (0.48 μmol/L) or higher declined from 3.3% in 1988-1994 to 0.7% in 1999-2002 ( P Conclusions Blood lead levels continue to decline among US adults, but racial and ethnic disparities persist. Higher blood lead levels remain associated with a higher burden of chronic kidney and peripheral arterial diseases among the overall population and with hypertension among non-Hispanic blacks and Mexican Americans.
264 citations
••
Commonwealth Scientific and Industrial Research Organisation1, University of Notre Dame2, University of Yamanashi3, Queensland University of Technology4, United States Environmental Protection Agency5, Geelong Football Club6, Tulane University7, Chulabhorn Research Institute8, University of South Florida9, University of Queensland10, University of York11, Hokkaido University12
TL;DR: Wastewater-based epidemiology (WBE) demonstrates potential for COVID-19 community monitoring; however, data on the stability of SARS-CoV-2 RNA in wastewater are needed to interpret WBE results, and MHV is suggested as suitable persistence surrogate.
264 citations
Authors
Showing all 24722 results
Name | H-index | Papers | Citations |
---|---|---|---|
Walter C. Willett | 334 | 2399 | 413322 |
JoAnn E. Manson | 270 | 1819 | 258509 |
Frank B. Hu | 250 | 1675 | 253464 |
Eric B. Rimm | 196 | 988 | 147119 |
Krzysztof Matyjaszewski | 169 | 1431 | 128585 |
Nicholas J. White | 161 | 1352 | 104539 |
Tien Yin Wong | 160 | 1880 | 131830 |
Tomas Hökfelt | 158 | 1033 | 95979 |
Thomas E. Starzl | 150 | 1625 | 91704 |
Geoffrey Burnstock | 141 | 1488 | 99525 |
Joseph Sodroski | 138 | 542 | 77070 |
Glenn M. Chertow | 128 | 764 | 82401 |
Darwin J. Prockop | 128 | 576 | 87066 |
Kenneth J. Pienta | 127 | 671 | 64531 |
Charles Taylor | 126 | 741 | 77626 |